Management of Patients With Chronic Hepatitis B (Hepadnaviridae) and Chronic Hepatitis D Infection (Deltavirus)

Milan J. Sonneveld; Suzanne van Meer

doi:10.1016/B978-0-12-814515-9.00104-1

Management of Patients With Chronic Hepatitis B (Hepadnaviridae) and Chronic Hepatitis D Infection (Deltavirus)

Milan J. Sonneveld
, Suzanne van Meer

Gastroenterology & Hepatology

University Medical Centre Utrecht

Research output: Chapter/Conference proceeding › Chapter › Academic

Abstract

Both chronic hepatitis B (CHB) and hepatitis D (CHD) are major causes of liver related morbidity and mortality. Treatment indications for CHB are based on level of viremia, inflammation and extent of fibrosis. Treatment may consist of finite pegylated interferon therapy or long-term treatment with nucleo(s)tide analogs. For CHD only pegylated interferon is effective in a subset of patients.

Original language	English
Title of host publication	Encyclopedia of Virology
Subtitle of host publication	Volume 1-5, Fourth Edition
Publisher	Elsevier Inc.
Pages	217-226
Number of pages	10
Volume	1-5
ISBN (Electronic)	9780128145166
DOIs	https://doi.org/10.1016/B978-0-12-814515-9.00104-1
Publication status	Published - 2021

Bibliographical note

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/B978-0-12-814515-9.00104-1

Cite this

@inbook{5a17b0bdb9274fa3ac41091bd758ab2f,

title = "Management of Patients With Chronic Hepatitis B (Hepadnaviridae) and Chronic Hepatitis D Infection (Deltavirus)",

abstract = "Both chronic hepatitis B (CHB) and hepatitis D (CHD) are major causes of liver related morbidity and mortality. Treatment indications for CHB are based on level of viremia, inflammation and extent of fibrosis. Treatment may consist of finite pegylated interferon therapy or long-term treatment with nucleo(s)tide analogs. For CHD only pegylated interferon is effective in a subset of patients.",

author = "Sonneveld, \{Milan J.\} and \{van Meer\}, Suzanne",

year = "2021",

doi = "10.1016/B978-0-12-814515-9.00104-1",

language = "English",

volume = "1-5",

pages = "217--226",

booktitle = "Encyclopedia of Virology",

publisher = "Elsevier Inc.",

address = "United States",

}

TY - CHAP

T1 - Management of Patients With Chronic Hepatitis B (Hepadnaviridae) and Chronic Hepatitis D Infection (Deltavirus)

AU - Sonneveld, Milan J.

AU - van Meer, Suzanne

PY - 2021

Y1 - 2021

N2 - Both chronic hepatitis B (CHB) and hepatitis D (CHD) are major causes of liver related morbidity and mortality. Treatment indications for CHB are based on level of viremia, inflammation and extent of fibrosis. Treatment may consist of finite pegylated interferon therapy or long-term treatment with nucleo(s)tide analogs. For CHD only pegylated interferon is effective in a subset of patients.

AB - Both chronic hepatitis B (CHB) and hepatitis D (CHD) are major causes of liver related morbidity and mortality. Treatment indications for CHB are based on level of viremia, inflammation and extent of fibrosis. Treatment may consist of finite pegylated interferon therapy or long-term treatment with nucleo(s)tide analogs. For CHD only pegylated interferon is effective in a subset of patients.

UR - https://www.scopus.com/pages/publications/85148824150

U2 - 10.1016/B978-0-12-814515-9.00104-1

DO - 10.1016/B978-0-12-814515-9.00104-1

M3 - Chapter

AN - SCOPUS:85148824150

VL - 1-5

SP - 217

EP - 226

BT - Encyclopedia of Virology

PB - Elsevier Inc.

ER -

Management of Patients With Chronic Hepatitis B (Hepadnaviridae) and Chronic Hepatitis D Infection (Deltavirus)

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this